NextFin News - James van Geelen, the founder of independent investment-research shop Citrini Research, has sold the firm to SemiAnalysis, the semiconductor and artificial-intelligence research outfit, and is planning to launch a new fund. Van Geelen and Dylan Patel, chief executive of SemiAnalysis, confirmed the transaction on Friday, September 11, 2026. Van Geelen will remain chief executive of Citrini Research for the time being. The sale price was not disclosed. The deal closes one of the more unusual chapters in recent market history: a 33-year-old former paramedic with no traditional Wall Street background built a research brand on Substack influential enough that a single free post in February helped trigger a broad stock selloff — and is now exiting into asset management.
The Deal: A Research Shop Changes Hands
The sale was confirmed by both parties. Van Geelen will stay on as CEO of Citrini Research for now, suggesting a transition period rather than an immediate handover. SemiAnalysis, founded and run by Patel, has built its reputation on deep-dive semiconductor supply-chain and AI infrastructure research — a natural thematic fit for a research shop whose most viral work centered on AI's economic consequences.
The financial terms were not disclosed. That opacity is itself a signal about the market for independent research assets: there is no public comparable for what a Substack-native research brand with a large paid subscriber base is worth, so pricing is being discovered deal by deal.
Citrini Research, formally Citrinitas Capital Management Inc., does not manage outside money — it sells research subscriptions. But it has already dipped a toe into fund structures. A prospectus filing for RoboStrategy Inc., a closed-end fund focused on equity and equity-linked investments in robotics and embodied AI companies, lists Citrinitas as a selling shareholder registering 50,000 shares for potential resale, or 0.25% of the shares being registered. The new fund van Geelen is planning would mark a more decisive shift: from selling analysis to managing capital.
Patel, for his part, has already moved SemiAnalysis in the same direction. SEC filings show SemiAnalysis is raising a $400 million venture fund, SemiAnalysis Capital Fund I, managed by Patel, targeting AI infrastructure companies the firm has long analyzed. Patel previously raised $50 million to invest in AI infrastructure company Fluidstack and holds stakes in roughly 20 startups, including Thinking Machines Lab and chip company Enfabrica. The Citrini deal pairs two research brands whose founders are both converting analysis into ownership.
How a Free Post Moved the Market
The context for this sale is the event that made Citrini a household name on trading desks. On a Sunday in late February 2026, the firm published "The 2028 Global Intelligence Crisis," a more than 7,000-word scenario describing a hypothetical future in which AI-driven mass white-collar layoffs create a deflationary cascade, pushing unemployment above 10% while stock prices are wiped out. The piece was explicitly framed as a scenario, not a forecast. Its preface asked: "What if our AI bullishness continues to be right...and what if that's actually bearish?"
By Monday morning the post was the talk of the market. When trading opened, the selling started. The S&P 500 Index went from green to red and closed down more than 1%. A gauge of financial shares had its worst session since April. A major software exchange-traded fund tumbled more than 4%. The report had named specific companies — ServiceNow, DoorDash, American Express — and those shares sank. Citrini held no short positions in any of them.
"If I thought that stocks were gonna move on this, I wouldn't have made it free," van Geelen said at the time, from Miami, where he was meeting clients.
"The market is clearly jumpy about this," he added.
The episode revealed how fragile market sentiment around AI had become. Investors had already spent weeks selling industries exposed to AI disruption — software, insurance brokerage, wealth management, cybersecurity. On that Monday, tariff concerns, geopolitics, and worries about another AI tool from Anthropic layered on top of the Citrini report to send equities careening. The stocks punished on Monday rebounded with the broader market on Tuesday, but the one-day panic exposed a market searching for a reason to sell.
Who Is James van Geelen
Van Geelen's biography reads like an argument against credentialism in finance. He trained for medicine, earned degrees in biology and psychology from UCLA, and worked as a paramedic in Los Angeles before abandoning medical school. In 2013 he founded an alternative-medicine company, which he sold to a private-equity firm in 2018, and used the proceeds to begin investing his own capital and writing research.
He started publishing under the Citrini name in 2023 and began monetizing behind a paywall that same year. His first claim to attention came in late 2022, when he published analysis arguing for shorting Silicon Valley Bank ahead of its March 2023 collapse. He then gained a following for early calls on artificial intelligence and GLP-1 weight-loss drugs. In July 2025, when rumors circulated that President Donald Trump might dismiss Federal Reserve Chair Jerome Powell, Citrini sent clients a yield-curve steepening trade — buy two-year Treasuries, short 10-year notes — that the market dubbed the "Powell Hedge."
The firm is based in New York with roughly 10 employees. One market newsletter tracking service put its portfolio return at more than 200% since May 2023. Its research spans modern warfare, humanoid robots, GLP-1 drugs, and broader macro trends, and it has ranked among Substack's top paid newsletters.
The February report was co-authored with Alap Shah, a friend who became a Citrini contributor. Shah is chief executive of AI firm Littlebird and managing partner at Lotus Technology Management. Shah disclosed that his firm held short positions in companies it believes will be disrupted by AI, alongside long positions — such as semiconductors — that benefit from AI. That disclosure later fueled debate about whether the report's authors were positioned to profit from the very selloff their words helped accelerate.
The Bigger Story: Independent Research Enters Consolidation
The sale to SemiAnalysis is more than a founder's exit. It is evidence that the independent research industry is entering a consolidation phase. For most of the 2020s, the economics of financial media favored atomization: a single analyst with a Substack, an X account, and a payment processor could reach tens of thousands of subscribers without a bank, a compliance department, or a distribution desk. Citrini was the archetype — a firm with 10 employees moving the S&P 500.
But atomization has a ceiling. Independent research brands face three structural pressures that make selling to a larger platform rational.
Scale in distribution and sales. A solo or small-team newsletter can reach a loyal niche, but institutional and high-net-worth distribution requires a sales force, a brand with staying power, and bundling power that one newsletter cannot match. SemiAnalysis already had an institutional footprint in semiconductor and AI infrastructure research; adding Citrini's macro and thematic equity audience creates a cross-selling base neither had alone.
The research-to-capital pipeline. The most lucrative endpoint for a research franchise is not subscriptions — it is assets under management. Newsletter revenue recurs, but fund management fees on real capital compound faster. Van Geelen's plan to launch a new fund is the logical next step: he has spent years building a track record and a brand; the sale gives him the balance sheet and freedom to convert that into a fund.
Regulatory and reputational risk. The February episode showed how much market-moving power now sits outside regulated sell-side desks. A free post with no compliance review moved billions in market value. Bringing independent research inside a larger, more established platform spreads that risk and subjects it to more formal controls.
This is a structural shift, not a cyclical one. The infrastructure that enabled independent financial media — Substack, social amplification, low-cost payment processing — is not going away, but the growth phase of atomization is. The next phase is aggregation: the strongest independent brands will be absorbed by larger research platforms, media companies, or asset managers, and founders will convert audience equity into fund equity.
The Conflict Question That Won't Go Away
Van Geelen's next act — launching a fund — sharpens a question that has trailed Citrini since February: what happens when the people writing market-moving research also have positions that benefit from the move?
During the February episode, Shah disclosed that his firm held shorts in companies it believed AI would disrupt. The report itself was free, but Citrini's paid research included model portfolios and trading alerts. There is no allegation of wrongdoing — scenario analysis is legitimate, and disclosure was made. But the episode demonstrated a new transmission mechanism in markets: research published on social media can move prices fast enough that anyone positioned ahead of it, or alongside it, benefits.
If van Geelen launches a fund that trades on the same thematic convictions his research publishes, the conflict-management framework matters more than ever. The industry's answer so far has been disclosure — Shah disclosed his shorts. But disclosure is a transparency tool, not a guardrail. The structural question is whether research-and-fund hybrids can maintain credibility when their words move the assets they hold.
There is a precedent for the tension. Sell-side research was once bundled with investment banking, and the conflicts were severe enough that regulators imposed Chinese walls and settlement agreements. The Substack era recreated a version of the problem in a less regulated setting. Van Geelen's move from pure research into money management will test whether the market tolerates research-and-capital combinations when the research brand itself is the marketing engine.
What This Means for the Market
For investors, the consolidation of independent research has two consequences. First, the era of the lone analyst moving markets with a free post is likely to narrow — not because the analysts disappear, but because their work gets absorbed into larger platforms with more formal distribution and, eventually, more formal controls. That could reduce the frequency of single-post selloffs, though it will not eliminate them; social amplification still rewards the most provocative framing.
Second, the line between research and asset management will keep blurring. SemiAnalysis itself has moved into venture investing — SEC filings show its $400 million venture fund targeting AI infrastructure companies the firm has long analyzed. When the analyst becomes the investor, the research product changes: it becomes both a marketing channel and a sourcing tool for deals.
For the AI trade specifically, the Citrini episode is now part of market folklore. Traders have a name for the phenomenon — the "scare trade" — and they know that AI sentiment is jumpy enough that a well-argued dystopian scenario can move prices even when the author insists it is not a forecast. That creates a persistent fragility: the market has learned to react to AI risk narratives, which means future narratives will get reactions whether or not they deserve them.
The Counter-Thesis: This Is Just One Founder's Exit
The strongest argument against reading this as an industry inflection point is the simplest one: it may just be one 33-year-old's decision to cash out and try fund management. Van Geelen never intended to go into finance; he trained as a doctor. He has already sold one company — the alternative-medicine business — and may simply be repeating a pattern he knows. SemiAnalysis may have bought Citrini for its subscriber base and brand, with no broader consolidation strategy. If Citrini operates largely unchanged under van Geelen's continued CEO tenure, and if his new fund never launches or fails to attract meaningful capital, then this deal is an anecdote, not a trend.
The falsifying signal is observable. If, over the next 12 to 18 months, other prominent independent research brands — Substack finance newsletters with large paid followings — announce similar sales to larger research platforms or asset managers, the consolidation thesis is confirmed. If instead independent research continues to fragment, with more solo analysts launching newsletters and none selling, then this was an isolated exit driven by one founder's circumstances.
What to Watch
Short term (months): Whether van Geelen's new fund launches, its strategy, and how much capital it raises. Also whether Citrini's research output and tone change under SemiAnalysis ownership — a shift toward more conservative framing would signal the compliance integration that consolidation implies.
Medium term (6–18 months): Whether other independent research brands announce sales. A cluster of deals would confirm the aggregation phase. Also worth watching: whether SemiAnalysis integrates Citrini's audience into its institutional product or keeps it as a standalone subscription.
Long term (years): Whether the research-and-fund model proves durable. If van Geelen's fund performs well while his research retains credibility, the hybrid model becomes a template. If conflicts erode trust or performance disappoints, the market will have relearned why research and money management were separated in the first place.
The central judgment: the Citrini sale is the first clear data point that the independent research boom of the 2020s is entering its consolidation phase. The founders who moved markets with newsletters are now selling those newsletters and converting audience into assets under management. That is a structural shift in how financial insight is produced, distributed, and monetized — and it will reshape both the research industry and the market's reaction function to the ideas it publishes.
The kicker: a free Substack post once moved the S&P 500; the man who wrote it has now sold the brand that post built. The question is not whether independent research survives — it is whether it survives as research, or becomes the marketing department of the funds it once analyzed.
Explore more exclusive insights at nextfin.ai.
